FDAnews
www.fdanews.com/articles/115395-mannkind-to-buy-pfizer-8217-s-insulin-plant-in-germany

MannKind to Buy Pfizer’s Insulin Plant in Germany

March 13, 2009
MannKind Corp said it has agreed to buy Pfizer Inc’s insulin manufacturing facility at Frankfurt, Germany and related assets for $33 million, giving the company access to an immediate supply of insulin, even if it is unable to acquire the facility itself.
CNBC